We are live on ! Find out more
IVVD icon

Invivyd

86 hedge funds and large institutions have $321M invested in Invivyd in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,754% more call options, than puts

Call options by funds: $4.01M | Put options by funds: $104K

540% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 5

46% more capital invested

Capital invested by funds: $220M → $321M (+$101M)

46% more funds holding

Funds holding: 5986 (+27)

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

15.05% more ownership

Funds ownership: 50.67%65.72% (+15%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
86
Holders Change
+27
Holders Change %
+45.76%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
32
Increased
25
Reduced
18
Closed
5
Calls
$4.01M
Puts
$104K
Net Calls
+$3.9M
Net Calls Change
+$3.46M

IVVD Hedge Fund Activity: Q1 2024 in Review

86 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Invivyd (IVVD) for Q1 2024, worth a combined $321M — up 46% from $220M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new IVVD positions and 5 closed out — a net gain of 27 holders — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $45.3M. The largest seller was OrbiMed, cutting an estimated $5.94M.

  • 86 institutional investors held Invivyd (IVVD) as of Q1 2024, up from 59 in Q4 2023.
  • Funds reported $321M of Invivyd stock for Q1 2024, up 46% quarter-over-quarter.
  • 32 funds opened new Invivyd positions in Q1 2024 and 5 closed out, a net change of +27 holders.
  • The largest Invivyd buyer in Q1 2024 was Deep Track Capital, an estimated $45.3M added.
  • The largest Invivyd seller in Q1 2024 was OrbiMed, an estimated $5.94M sold.

Based on aggregated 13F filings for Q1 2024.